Beta Carotene

Beta Carotene

SCHEMBL2300399

CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 1.00
PTGS1 P23219 4/20 1.00
LMNA P02545 3/20 1.00
DRD3 P35462 2/20 1.00
SLCO1B3 Q9NPD5 2/20 1.00
SLCO1B1 Q9Y6L6 2/20 1.00
APP P05067 4/20 0.85
SNCA P37840 4/20 0.85
CYP3A4 P08684 7/20 0.84
ALOX15 P16050 5/20 0.84
TDP1 Q9NUW8 3/20 0.84
TSHR P16473 2/20 0.84
TP53 P04637 2/20 0.84
NR2E1 Q9Y466 1/20 0.84
MAPT P10636 9/20 0.80
RXRA P19793 5/20 0.80
RARA P10276 4/20 0.80
RARB P10826 4/20 0.80
RARG P13631 4/20 0.80
MAPK1 P28482 4/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Beta Carotene SCHEMBL26362434 1.00 ALDH1A1 (1.00) ALDH1A1PTGS1LMNADRD3SLCO1B3
Beta Carotene SCHEMBL29636150 1.00 ALDH1A1 (1.00) ALDH1A1PTGS1LMNADRD3SLCO1B3
Beta Carotene SCHEMBL29445419 1.00 ALDH1A1 (1.00) ALDH1A1PTGS1LMNADRD3SLCO1B3
Beta Carotene SCHEMBL15066330 1.00 ALDH1A1 (1.00) ALDH1A1PTGS1LMNADRD3SLCO1B3
Beta Carotene SCHEMBL5316237 1.00 ALDH1A1 (1.00) ALDH1A1PTGS1LMNADRD3SLCO1B3
Beta Carotene SCHEMBL6151 1.00 ALDH1A1 (1.00) ALDH1A1PTGS1LMNADRD3SLCO1B3
Beta Carotene SCHEMBL29360574 1.00 ALDH1A1 (1.00) ALDH1A1PTGS1LMNADRD3SLCO1B3
Beta Carotene SCHEMBL135090 1.00 ALDH1A1 (1.00) ALDH1A1PTGS1LMNADRD3SLCO1B3
Beta Carotene SCHEMBL20996197 1.00 ALDH1A1 (1.00) ALDH1A1PTGS1LMNADRD3SLCO1B3
Beta Carotene SCHEMBL16114545 0.98 ALDH1A1 (0.97) ALDH1A1PTGS1LMNADRD3SLCO1B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4750804-B2 2011-08-17 JP claimed
JP-2008531514-A 2008-08-14 JP claimed
EP-1850664-A2 PESTICIDAL CAPSULE FORMULATION Syngeta Participations AG (CH) 2007-11-07 EP claimed
WO-2006089747-A2 PRESTICIDAL CAPSULE FORMULATION SYNGENTA PARTICIPATIONS AG (CH) 2006-08-31 WO claimed
US-20260123659-A1 NUTRITIONAL FORMULA BUILDING BLOCK NUTRITIONALS LLC (US) 2026-05-07 US disclosed
US-20250281271-A1 TISSUE STORAGE, IRRIGATION, AND INFUSION MEDIUM AND METHODS OF USE NEW YORK SOC FOR THE RELIEF OF THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL (US) 2025-09-11 US disclosed
US-12302934-B2 Nutritional formula BUILDING BLOCK NUTRITIONALS, LLC (US) 2025-05-20 US disclosed
US-20250134095-A1 COMPOSITIONS FOR ORGAN AND TISSUE PRESERVATION ALBERT EINSTEIN COLLEGE MEDICINE (US) 2025-05-01 US disclosed
EP-4511084-A1 TISSUE STORAGE, IRRIGATION, AND INFUSION MEDIUM AND METHODS OF USE New York Society for the Relief of the Ruptured and Crippled, Maintaining the Hospital for Special Surgery (US) 2025-02-26 EP disclosed
US-20250018358-A1 Systems and Methods for Processing Gases CARBOGENESIS LLC 2025-01-16 US disclosed
WO-2023205339-A1 TISSUE STORAGE, IRRIGATION, AND INFUSION MEDIUM AND METHODS OF USE NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY (US) 2023-10-26 WO disclosed
US-20230232884-A1 NUTRITIONAL FORMULA BUILDING BLOCK NUTRITIONALS, LLC (US) 2023-07-27 US disclosed
US-20110065083-A1 Compositions and Methods for Enhancing the Viability of Animal Cells, Tissues, and Organ Explants WARSAW ORTHOPEDIC, INC. (US) 2011-03-17 US disclosed
EP-2205697-A1 METHODS FOR REFINING HYDROCARBON FEEDSTOCKS Sapphire Energy, Inc. (US) 2010-07-14 EP disclosed
US-20090126260-A1 METHODS OF REFINING HYDROCARBON FEEDSTOCKS SAPPHIRE ENERGY, INC (US) 2009-05-21 US disclosed
WO-2009039201-A1 METHODS FOR REFINING HYDROCARBON FEEDSTOCKS SAPPHIRE ENERGY, INC. (US) 2009-03-26 WO disclosed
US-20090017439-A1 COMPOSITIONS AND METHODS FOR ENHANCING THE VIABILITY OF ANIMAL CELLS, TISSUES, AND ORGAN EXPLANTS WARSAW ORTHOPEDIC, INC. (US) 2009-01-15 US disclosed
US-20090017438-A1 METHODS AND COMPOSITIONS FOR THE PRESERVATION OF CELLS AND TISSUES WARSAW ORTHOPEDIC, INC. (US) 2009-01-15 US disclosed
EP-1850664-A2 PESTICIDAL CAPSULE FORMULATION Syngeta Participations AG (CH) 2007-11-07 EP disclosed
WO-2006089747-A2 PRESTICIDAL CAPSULE FORMULATION SYNGENTA PARTICIPATIONS AG (CH) 2006-08-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250134095-A1 COMPOSITIONS FOR ORGAN AND TISSUE PRESERVATION PIGS, ALPG, ALPP ALDH1A1 1110/4885PTGS1 1192/4885LMNA 532/4885
US-20260123659-A1 NUTRITIONAL FORMULA FABP2, LPO, LPL ALDH1A1 3727/4885PTGS1 347/4885LMNA 2379/4885
US-20230232884-A1 NUTRITIONAL FORMULA FABP2, ALOX5, LPO ALDH1A1 3812/4885PTGS1 528/4885LMNA 2111/4885
US-20250018358-A1 Systems and Methods for Processing Gases F2, AHR, ACSS2 ALDH1A1 4082/4885PTGS1 979/4885LMNA 1378/4885
US-12302934-B2 Nutritional formula FABP2, ALOX5, LPO ALDH1A1 3812/4885PTGS1 528/4885LMNA 2111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.